Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)

Abstract

This investigation examines pharmacovigilance databases to find the most common adverse effects associated with voriconazole. I performed a statistical analysis of voriconazole adverse events using data from the FDA's Adverse Event Reporting System (FAERS). Each adverse event was assigned a frequency and reported odds ratio (ROR). A total of 2511 reports were produced by the FAERS database. While voriconazole remains an important medicine for fungal treatment, the adverse reactions associated with voriconazole should be considered. The Major five adverse effect of voriconazole was highlighted in this study based on the highest number of signals received.